The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies

Christine G. Joseph, Krista R. Wilson, Michael S. Wood, Nicholas B. Sorenson, Dong V. Phan, Zhimin Xiang, Rachel M. Witek, Carrie Haskell-Luevano

Research output: Contribution to journalArticle

Abstract

The melanocortin system consists of five seven-transmembrane spanning G-protein coupled receptors (MC1-5) that are stimulated by endogenous agonists and antagonized by the only two known endogenous antagonists of GPCRs, agouti and agouti-related protein (AGRP). These receptors have been associated with many physiological functions, including the involvement of the MC4R in feeding behavior and energy homeostasis, making this system an attractive target for the treatment of obesity. Small-molecule mimetics of endogenous ligands may result in the development of compounds with properties more suitable for use as therapeutic agents. The research presented herein involves the synthesis and analysis of 12 melanocortin receptor agonists using the 1,4-benzodiazepine-2,5- dione template and is the first report of these derivatives as melanocortin receptor agonists. Structure-activity relationship studies using this privileged structure template has resulted in molecules with molecular weights around 400 that possess nanomolar agonist potency at the melanocortin receptors examined in this study.

Original languageEnglish (US)
Pages (from-to)1423-1431
Number of pages9
JournalJournal of Medicinal Chemistry
Volume51
Issue number5
DOIs
StatePublished - Mar 13 2008
Externally publishedYes

Fingerprint

Melanocortin Receptors
Molecules
Agouti-Related Protein
Melanocortins
Therapeutic Uses
Feeding Behavior
Structure-Activity Relationship
G-Protein-Coupled Receptors
Homeostasis
Obesity
Molecular Weight
Molecular weight
Ligands
Derivatives
Research
Bz-423

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Joseph, C. G., Wilson, K. R., Wood, M. S., Sorenson, N. B., Phan, D. V., Xiang, Z., ... Haskell-Luevano, C. (2008). The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies. Journal of Medicinal Chemistry, 51(5), 1423-1431. https://doi.org/10.1021/jm701303z

The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies. / Joseph, Christine G.; Wilson, Krista R.; Wood, Michael S.; Sorenson, Nicholas B.; Phan, Dong V.; Xiang, Zhimin; Witek, Rachel M.; Haskell-Luevano, Carrie.

In: Journal of Medicinal Chemistry, Vol. 51, No. 5, 13.03.2008, p. 1423-1431.

Research output: Contribution to journalArticle

Joseph, CG, Wilson, KR, Wood, MS, Sorenson, NB, Phan, DV, Xiang, Z, Witek, RM & Haskell-Luevano, C 2008, 'The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies', Journal of Medicinal Chemistry, vol. 51, no. 5, pp. 1423-1431. https://doi.org/10.1021/jm701303z
Joseph, Christine G. ; Wilson, Krista R. ; Wood, Michael S. ; Sorenson, Nicholas B. ; Phan, Dong V. ; Xiang, Zhimin ; Witek, Rachel M. ; Haskell-Luevano, Carrie. / The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies. In: Journal of Medicinal Chemistry. 2008 ; Vol. 51, No. 5. pp. 1423-1431.
@article{3c956dffa8104f9092a5bb78c0809636,
title = "The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies",
abstract = "The melanocortin system consists of five seven-transmembrane spanning G-protein coupled receptors (MC1-5) that are stimulated by endogenous agonists and antagonized by the only two known endogenous antagonists of GPCRs, agouti and agouti-related protein (AGRP). These receptors have been associated with many physiological functions, including the involvement of the MC4R in feeding behavior and energy homeostasis, making this system an attractive target for the treatment of obesity. Small-molecule mimetics of endogenous ligands may result in the development of compounds with properties more suitable for use as therapeutic agents. The research presented herein involves the synthesis and analysis of 12 melanocortin receptor agonists using the 1,4-benzodiazepine-2,5- dione template and is the first report of these derivatives as melanocortin receptor agonists. Structure-activity relationship studies using this privileged structure template has resulted in molecules with molecular weights around 400 that possess nanomolar agonist potency at the melanocortin receptors examined in this study.",
author = "Joseph, {Christine G.} and Wilson, {Krista R.} and Wood, {Michael S.} and Sorenson, {Nicholas B.} and Phan, {Dong V.} and Zhimin Xiang and Witek, {Rachel M.} and Carrie Haskell-Luevano",
year = "2008",
month = "3",
day = "13",
doi = "10.1021/jm701303z",
language = "English (US)",
volume = "51",
pages = "1423--1431",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies

AU - Joseph, Christine G.

AU - Wilson, Krista R.

AU - Wood, Michael S.

AU - Sorenson, Nicholas B.

AU - Phan, Dong V.

AU - Xiang, Zhimin

AU - Witek, Rachel M.

AU - Haskell-Luevano, Carrie

PY - 2008/3/13

Y1 - 2008/3/13

N2 - The melanocortin system consists of five seven-transmembrane spanning G-protein coupled receptors (MC1-5) that are stimulated by endogenous agonists and antagonized by the only two known endogenous antagonists of GPCRs, agouti and agouti-related protein (AGRP). These receptors have been associated with many physiological functions, including the involvement of the MC4R in feeding behavior and energy homeostasis, making this system an attractive target for the treatment of obesity. Small-molecule mimetics of endogenous ligands may result in the development of compounds with properties more suitable for use as therapeutic agents. The research presented herein involves the synthesis and analysis of 12 melanocortin receptor agonists using the 1,4-benzodiazepine-2,5- dione template and is the first report of these derivatives as melanocortin receptor agonists. Structure-activity relationship studies using this privileged structure template has resulted in molecules with molecular weights around 400 that possess nanomolar agonist potency at the melanocortin receptors examined in this study.

AB - The melanocortin system consists of five seven-transmembrane spanning G-protein coupled receptors (MC1-5) that are stimulated by endogenous agonists and antagonized by the only two known endogenous antagonists of GPCRs, agouti and agouti-related protein (AGRP). These receptors have been associated with many physiological functions, including the involvement of the MC4R in feeding behavior and energy homeostasis, making this system an attractive target for the treatment of obesity. Small-molecule mimetics of endogenous ligands may result in the development of compounds with properties more suitable for use as therapeutic agents. The research presented herein involves the synthesis and analysis of 12 melanocortin receptor agonists using the 1,4-benzodiazepine-2,5- dione template and is the first report of these derivatives as melanocortin receptor agonists. Structure-activity relationship studies using this privileged structure template has resulted in molecules with molecular weights around 400 that possess nanomolar agonist potency at the melanocortin receptors examined in this study.

UR - http://www.scopus.com/inward/record.url?scp=41649108801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649108801&partnerID=8YFLogxK

U2 - 10.1021/jm701303z

DO - 10.1021/jm701303z

M3 - Article

C2 - 18271518

AN - SCOPUS:41649108801

VL - 51

SP - 1423

EP - 1431

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 5

ER -